Altimmune Inc (NASDAQ: ALT) is -9.07% lower on its value in year-to-date trading and has touched a low of $2.09 and a high of $14.84 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ALT stock was last observed hovering at around $10.18 in the last trading session, with the day’s gains setting it 0.05%.
Currently trading at $10.23, the stock is 2.65% and 2.87% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.08 million and changing 0.49% at the moment leaves the stock 83.59% off its SMA200. ALT registered 134.10% gain for a year compared to 6-month gain of 309.20%. The firm has a 50-day simple moving average (SMA 50) of $1.23k and a 200-day simple moving average (SMA200) of -$5.94.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -15.45% loss in the last 1 month and extending the period to 3 months gives it a -11.96%, and is 12.67% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.41% over the week and 9.71% over the month.
Altimmune Inc (ALT) has around 59 employees, a market worth around $549.66M and $0.43M in sales. Profit margin for the company is -20762.21%. Distance from 52-week low is 389.47% and -31.06% from its 52-week high. The company has generated returns on investments over the last 12 months (-45.53%).
Altimmune Inc quarterly earnings per share for the current quarter are estimated at -$0.37.The EPS is expected to shrink by -4.22% this year, but quarterly earnings will post 8,282.60% year-over-year.
Altimmune Inc (ALT) Top Institutional Holders
187 institutions hold shares in Altimmune Inc (ALT), with institutional investors hold 52.04% of the company’s shares. The shares outstanding are 70.68M, and float is at 53.18M with Short Float at 23.53%. Institutions hold 51.63% of the Float.
The top institutional shareholder in the company is Blackrock Inc. with over 3.66 million shares valued at $12.93 million. The investor’s holdings represent 6.95% of the ALT Shares outstanding. As of Jun 29, 2023, the second largest holder is Nuveen Asset Management, LLC with 3.46 million shares valued at $12.21 million to account for 6.57% of the shares outstanding. The other top investors are Vanguard Group Inc which holds 3.31 million shares representing 6.27% and valued at over $11.67 million, while Tang Capital Management, LLC holds 5.22% of the shares totaling 2.75 million with a market value of $9.71 million.
Altimmune Inc (ALT) Insider Activity
The most recent transaction is an insider purchase by Drutz David,the company’sDirector. SEC filings show that Drutz David bought 300 shares of the company’s common stock on Aug 15 ’23 at a price of $2.88 per share for a total of $862.0. Following the purchase, the insider now owns 29785.0 shares.
